A Welcome Produce Alert: OIG Signals a Practical Path Forward for Food as Medicine Programs in Advisory Opinion 26-16
The healthcare industry has increasingly embraced "Food as Medicine" as providers and payors recognize the role nutrition plays in managing chronic disease. From medical nutrition therapy to produce prescription programs and medically tailored meals, these initiatives have become an increasingly common component of value-based care strategies aimed at improving outcomes while reducing downstream healthcare costs.
Despite growing policy support, these programs have long raised federal fraud and abuse concerns. Offering free food or grocery benefits to Medicare or Medicaid beneficiaries can implicate both the federal Anti-Kickback Statute ("AKS") and the Beneficiary Inducements Civil Monetary Penalty ("CMP"), particularly when those benefits are connected to reimbursable healthcare services.
OIG Advisory Opinion 26-16 provides important insight into how the Office of Inspector General ("OIG") is approaching these arrangements. Although binding only on the requestor, the opinion sends the signal that OIG may be willing to exercise enforcement discretion when Food as Medicine programs are clinically integrated, tightly safeguarded, and designed primarily to improve patient outcomes rather than drive volume for reimbursable services.
Key Takeaways from OIG: 5 Compliance Principles
For digital health founders, health systems, and payors operating in the Food as Medicine space, Advisory Opinion 26-16 highlights five key compliance principles:
Remuneration Risk is Real: Free food provided to federal healthcare program beneficiaries is considered "remuneration" that can trigger both the AKS and CMP, even when intended to treat illness.
Exceptions May Not Apply Automatically: The OIG explicitly determined that tying free produce to required clinical visits disqualified the arrangement from the statutory Financial Need-Based Exception to the Beneficiary Inducements CMP.
Clinical Integration Matters: Rather than penalizing the entity, the OIG exercised enforcement discretion because the food benefit was embedded in an evidence-based, clinical care management program overseen by physicians, dietitians, and behavioral health experts.
Safeguards Mitigate Fraud Risk: Restricted-use vouchers, retailer MOUs, cashier training, receipt tracking, and limited program duration effectively demonstrated that the benefit was not an unlawful patient acquisition tool.
Focus on Value-Based Outcomes: Aligning the program with an organization's core clinical mission (in this case, HRSA-approved FQHC objectives) helped convince regulators that the primary goal was health outcome improvement.
Breakdown of the Approved Arrangement
To understand why the OIG greenlit this program, it is helpful to review how the requesting Federally Qualified Health Center (FQHC) structured its six-month initiative for 50 low-income patients diagnosed with diabetes or hypertension.
The Requestor, a federally qualified health center ("FQHC"), proposed a six-month food-as-medicine program for fifty financially needy patients with diabetes or hypertension.
Participants in the program would undergo a series of health assessments with a registered dietitian and behavioral health consultant involving a nutrition assessment, meal plan development, clinical laboratory testing, and counseling, among other services. This process was also overseen by a physician.
Participants would then receive weekly produce boxes or produce vouchers, nutrition counseling, behavioral health services, physician oversight, laboratory testing, and individualized care plans. While the produce boxes and vouchers would be provided free of charge, the FQHC would continue billing insurers, including Federal health care programs where appropriate, for reimbursable clinical services. The produce component would instead be funded through grants.
The Requestor also tracked data on redemption patterns, receipts, site visits, and MOUs with retailers accepting the vouchers, to ensure that the vouchers were only used to purchase healthy foods. Eligibility was based on clinical criteria, financial hardship, and existing patient status, not insurance coverage or anticipated reimbursement.
OIG's Analysis of the Arrangement
OIG expressly found that the free produce constituted remuneration (meaning, something of value) capable of implicating both AKS and CMP because it could encourage beneficiaries to obtain reimbursable services from the FQHC. Notably, OIG also concluded the arrangement failed to satisfy the statutory Financial Need-Based Exception to the Beneficiary Inducements CMP because the free produce was tied to reimbursable clinical services provided through the program.
However, rather than finding the arrangement lawful, OIG exercised its enforcement discretion and declined to impose administrative sanctions.
Why did OIG decline to impose sanctions?
Several factors reduced the perceived fraud and abuse risk.
Targeted for Outcome Improvements, NOT patient steering: The Food as Medicine program was integrated into a broader evidence-based care management program involving nutrition counseling, behavioral health, physician oversight, and individualized care planning. OIG viewed these services as medically appropriate and intended to improve patient outcomes rather than drive unnecessary utilization.
Low Risk of Unfair Competition: The food benefit itself was modest and carefully controlled. Participants received one produce box or restricted use voucher each week for only six months. Voucher safeguards, including receipt verification, retailer agreements, redemption tracking, and cashier training, limited the risk that participants could use the benefit for purposes unrelated to the program's clinical goals.
Evidence-Based Design: Integrating nutrition directly with physician-led care management ensured the program operated as a legitimate clinical intervention, aligning with the FQHC's HRSA-approved mission of providing nutrition-related services.
What are the Strategic Implications of AO 26-16 for Digital Health Companies, Payers, and Providers?
Although focused on produce benefits, Advisory Opinion 26-16 has implications well beyond food-as-medicine programs. Digital health companies, providers, and payors are increasingly incorporating social determinants of health into care delivery through initiatives involving food, transportation, housing support, and other non-clinical interventions. OIG may be receptive to these models where they are designed primarily to advance legitimate clinical objectives, include meaningful safeguards against fraud and abuse, and are not structured as patient acquisition tools.
At the same time, organizations should avoid reading the opinion too broadly. OIG repeatedly emphasized the arrangement's unique facts, including its limited duration, modest benefit, financial need screening, grant funding, operational safeguards, and the Requestor's status as an FQHC in expressly stating that the opinion applies only to the Requestor. For organizations developing Food as Medicine and other initiatives around social determinants, the opinion provides a useful framework for balancing innovation with fraud and abuse compliance.
Frequently Asked Questions:
What is OIG Advisory Opinion 26-16?
OIG Advisory Opinion 26-16 is a regulatory ruling issued by the HHS Office of Inspector General evaluating a six-month "Food as Medicine" program run by an FQHC. The OIG concluded that while free produce provided to patients constitutes remuneration under federal fraud and abuse laws, it would not impose administrative sanctions due to the program's strong clinical oversight, financial need controls, and operational safeguards.
Does giving free food to patients violate the Anti-Kickback Statute (AKS)?
It can. Under the Anti-Kickback Statute and the Beneficiary Inducements CMP, offering anything of value (including free food, produce vouchers, or grocery cards) to federal healthcare program beneficiaries can be viewed as an illegal inducement to steer patients toward reimbursable clinical services. However, properly structured programs with strong clinical integration and safeguards can significantly mitigate this regulatory risk.
Can venture-backed digital health startups rely on OIG Advisory Opinion 26-16?
Advisory opinions are legally binding only for the specific party that requested them. While Opinion 26-16 provides a helpful framework for how regulators view Food as Medicine models, commercial digital health startups operate under different corporate structures and funding mechanics than FQHCs. Startups should consult healthcare regulatory legal counsel to structure their specific business, data, and reimbursement models safely.
If you are launching or scaling a Food as Medicine initiative, Nixon Law Group is here to help. Contact us to schedule an introductory meeting.